Multi-Center, Open Label Study to Assess Early Response to Abatacept With Background Methotrexate Using Power Doppler Ultrasonography in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate.
Phase of Trial: Phase III
Latest Information Update: 25 May 2017
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms APPRAISE
- Sponsors Bristol-Myers Squibb
- 10 Jun 2017 Biomarkers information updated
- 20 Nov 2015 Results published in the Annals of the Rheumatic Diseases
- 13 Jun 2015 Post hoc analysis (effect of BMI on the efficacy of Abatacept) results presented at the 16th Annual Congress of the European League Against Rheumatism.